PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
120 hedge funds and large institutions have $262M invested in Progenics Pharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 44 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
18% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 44
32% less capital invested
Capital invested by funds: $383M → $262M (-$121M)
Holders
120
Holding in Top 10
1
Calls
$833K
Puts
$928K
Top Buyers
| 1 | +$1.68M | |
| 2 | +$1.5M | |
| 3 | +$1.01M | |
| 4 |
KAM
Kavi Asset Management
New York
|
+$984K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$948K |
Top Sellers
| 1 | -$4.21M | |
| 2 | -$2.92M | |
| 3 | -$2.69M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.57M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.16M |